CARSO Group has acquired a majority stake in AQCF Group
CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.
Founded in 1992 and hearquartered in France, CARSO Group is one of the leading providers of analytical services in the French market, with activities in neighboring countries. The wide range of analysis offered includes water and environment testing, occupational hygiene and building health, food, genetics and pharma analysis. In 2021, ARCHIMED became CARSO Group’s majority shareholder, in partnership with CAPZA, Siparex, the management team and the founders. Since becoming the majority shareholder, ARCHIMED has supported the company’s organic and external growth across Europe, through mergers and partnerships in the most attractive market segments. The common objective is to strengthen CARSO’s position as an independent, entrepreneurial and international platform in the world of analytical services.
Founded in 2007 and COFRAC-accredited, AQCF Group provides all players in the agri-food sector with its skills and know-how in quality, safety and environmental management, offering a wide range of analysis for food and water quality control, consultancy services in food hygiene and safety, consultancy services in laboratory layout and restructuring, and customized training.
Oaklins’ team in France advised CARSO Group and its shareholders on the acquisition of AQCF Group.
Talk to the deal team
Related deals
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Learn moreEbidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment
Ebidco S.r.l. has completed a voluntary public tender offer for the shares of Eles Semiconductor Equipment S.p.A.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn more